Regnum Corp.
Regnum Corp. (RGMP) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
rgmp · pe ratio · data through Dec 31, 2022
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Regnum Corp. (RGMP) measures how much investors pay for each dollar of the company's trailing earnings. RGMP's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.03.
Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31
PE Ratio History
2016 – 2022 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Regnum Corp.You RGMP | $0M | N/A | — | -$0.03 |
 Ampio Pharmaceuticals, Inc. AMPE | $0M | N/A | — | -$10.67 |
 Bioasis Technologies Inc. BIOAF | $0M | N/A | — | -$0.04 |
 Golden Developing Solutions, Inc. DVLP | $0M | N/A | — | -$0.00 |
 Lombard Medical, Inc. EVARF | $0M | N/A | — | -$1.54 |
 GB Sciences, Inc. GBLX | $0M | N/A | — | -$0.00 |
 GlobeStar Therapeutics Corporation GSTC | $0M | N/A | — | -$0.00 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2022-12-31Latest FY2022 | — | $-0.03 | — | |
2021-12-31 FY2021 | — | $-0.01 | — | |
2020-12-31 FY2020 | — | $-0.00 | — | |
2019-12-31 FY2019 | — | $-0.00 | — | |
2018-12-31 FY2018 | 1722.97x | $0.00 | -30.6% | |
2017-12-31 FY2017 | 2481.98x | $0.00 | — | |
2016-12-31 FY2016 | — | $-0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Regnum Corp. (RGMP) measures how much investors pay for each dollar of the company's trailing earnings. RGMP's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.03.
Frequently asked questions
RGMP pe ratio · 6 questionsRGMP's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.03. Data sourced from Financial Modeling Prep via RGMP's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Regnum Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09